Teratology society: presentation to the FDA public meeting on safety issues associated with the use of dietary supplements during pregnancy.
Friedman
J M
JM
Department of Medical Genetics, University of British Columbia, Vancouver, Canada V6T 1Z2.
D000014:Abnormalities, Drug-Induced; D019587:Dietary Supplements / Q000009:adverse effects*; D005260:Female; D006801:Humans; D019684:Magnoliopsida / Q000009:adverse effects*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced / Q000188:drug therapy; D018600:Teratology; D014481:United States; D014486:United States Food and Drug Administration